Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Scope of the Report:
Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
The global Drugs for Osteoarthritis Pain market is valued at 7440 million USD in 2018 and is expected to reach 10400 million USD by the end of 2024, growing at a CAGR of 5.8% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drugs for Osteoarthritis Pain.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Drugs for Osteoarthritis Pain market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drugs for Osteoarthritis Pain market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Injection
External

Market Segment by Applications, can be divided into
Medical Care
Personal Care